![Tango Therapeutics Inc](/common/images/company/N_TNGX.png)
Tango Therapeutics Inc (TNGX)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||||
総売上 | 6.41M | 5.77M | 14.6M | 10.73M | 5.43M | 6.47M | 19.88M | 11.61M |
営業利益 | -30.57M | -30.29M | -23.25M | -25.63M | -35.01M | -42.26M | -29.55M | -32.88M |
税引前収入 | -29.01M | -28.01M | -20.65M | -22.24M | -30.72M | -37.87M | -25.49M | -29.11M |
純利益 | -29.06M | -28.01M | -20.71M | -22.26M | -30.76M | -37.91M | -25.55M | -29.17M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -29.6M | -29.07M | -22.1M | -24.11M | -32.95M | -40.07M | -27.56M | -30.92M |
EBITDA | -30M | -29.71M | -22.64M | -25.01M | -34.4M | -41.63M | -28.92M | -32.26M |
年末 2023年12月31日 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 37.04M | 24.86M | 36.53M |
営業利益 | -181k | -58.19M | -111.07M | -114.17M |
税引前収入 | -116k | -57.94M | -108.12M | -101.61M |
純利益 | -123k | -58.24M | -108.18M | -101.74M |
優先配当 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.022 | -0.665 | -1.227 | -0.998 |
EBIT | -181k | -58.44M | -109.58M | -108.23M |
EBITDA | -181k | -57.29M | -109.46M | -111.76M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約